These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
442 related articles for article (PubMed ID: 16788759)
1. Initial outcomes for patients treated on the American Society of Breast Surgeons MammoSite clinical trial for ductal carcinoma-in-situ of the breast. Jeruss JS; Vicini FA; Beitsch PD; Haffty BG; Quiet CA; Zannis VJ; Keleher AJ; Garcia DM; Snider HC; Gittleman MA; Whitacre E; Whitworth PW; Fine RE; Arrambide S; Kuerer HM Ann Surg Oncol; 2006 Jul; 13(7):967-76. PubMed ID: 16788759 [TBL] [Abstract][Full Text] [Related]
2. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study. Benitez PR; Streeter O; Vicini F; Mehta V; Quiet C; Kuske R; Hayes MK; Arthur D; Kuerer H; Freedman G; Keisch M; Dipetrillo T; Khan D; Hudes R Am J Surg; 2006 Oct; 192(4):427-33. PubMed ID: 16978943 [TBL] [Abstract][Full Text] [Related]
3. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. Benitez PR; Keisch ME; Vicini F; Stolier A; Scroggins T; Walker A; White J; Hedberg P; Hebert M; Arthur D; Zannis V; Quiet C; Streeter O; Silverstein M Am J Surg; 2007 Oct; 194(4):456-62. PubMed ID: 17826055 [TBL] [Abstract][Full Text] [Related]
4. Factors associated with optimal cosmetic results at 36 months in patients treated with accelerated partial breast irradiation (APBI) on the American Society of Breast Surgeons (ASBrS) MammoSite Breast Brachytherapy Registry Trial. Goyal S; Khan AJ; Vicini F; Beitsch PD; Lyden M; Keisch M; Haffty BG Ann Surg Oncol; 2009 Sep; 16(9):2450-8. PubMed ID: 19517191 [TBL] [Abstract][Full Text] [Related]
5. Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI). Vicini F; Beitsch PD; Quiet CA; Keleher AJ; Garcia D; Snider HC; Gittleman MA; Zannis VJ; Kuerer HM; Lyden M Cancer; 2008 Feb; 112(4):758-66. PubMed ID: 18181095 [TBL] [Abstract][Full Text] [Related]
6. First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: results of the American Society of Breast Surgeons MammoSite breast brachytherapy trial. Vicini FA; Beitsch PD; Quiet CA; Keleher A; Garcia D; Snider HC; Gittleman MA; Zannis VJ; Kuerer H; Whitacre EB; Whitworth PW; Fine RE; Haffty BG; Arrambide LS Cancer; 2005 Sep; 104(6):1138-48. PubMed ID: 16088962 [TBL] [Abstract][Full Text] [Related]
7. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the william beaumont hospital experience. Chao KK; Vicini FA; Wallace M; Mitchell C; Chen P; Ghilezan M; Gilbert S; Kunzman J; Benitez P; Martinez A Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):32-40. PubMed ID: 17467920 [TBL] [Abstract][Full Text] [Related]
8. Acute complications of MammoSite brachytherapy: a single institution's initial clinical experience. Harper JL; Jenrette JM; Vanek KN; Aguero EG; Gillanders WE Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):169-74. PubMed ID: 15629608 [TBL] [Abstract][Full Text] [Related]
9. Local control, toxicity, and cosmesis in women younger than 50 enrolled onto the American Society of Breast Surgeons MammoSite Radiation Therapy System registry trial. Khan AJ; Vicini F; Beitsch P; Haffty B; Quiet C; Keleher A; Garcia D; Snider H; Gittleman M; Zannis V; Kuerer H; Whitacre E; Whitworth P; Fine R Ann Surg Oncol; 2009 Jun; 16(6):1612-8. PubMed ID: 19319606 [TBL] [Abstract][Full Text] [Related]
10. American Society of Breast Surgeons MammoSite Radiation Therapy System Registry Trial: ductal carcinoma-in-situ subset analysis--4-year data in 194 treated lesions. Keisch M; Vicini F; Beitsch P; Quiet C; Keleher A; Garcia D; Snider H; Gittleman M; Zannis V; Kuerer H Am J Surg; 2009 Oct; 198(4):505-7. PubMed ID: 19800456 [TBL] [Abstract][Full Text] [Related]
11. Four-year clinical update from the American Society of Breast Surgeons MammoSite brachytherapy trial. Nelson JC; Beitsch PD; Vicini FA; Quiet CA; Garcia D; Snider HC; Gittleman MA; Zannis VJ; Whitworth PW; Fine RE; Keleher AJ; Kuerer HM Am J Surg; 2009 Jul; 198(1):83-91. PubMed ID: 19268900 [TBL] [Abstract][Full Text] [Related]
12. Treatment efficacy with accelerated partial breast irradiation (APBI): final analysis of the American Society of Breast Surgeons MammoSite(®) breast brachytherapy registry trial. Shah C; Badiyan S; Ben Wilkinson J; Vicini F; Beitsch P; Keisch M; Arthur D; Lyden M Ann Surg Oncol; 2013 Oct; 20(10):3279-85. PubMed ID: 23975302 [TBL] [Abstract][Full Text] [Related]
13. Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma. Pawlik TM; Perry A; Strom EA; Babiera GV; Buchholz TA; Singletary E; Perkins GH; Ross MI; Schecter NR; Meric-Bernstam F; Ames FC; Hunt KK; Kuerer HM Cancer; 2004 Feb; 100(3):490-8. PubMed ID: 14745864 [TBL] [Abstract][Full Text] [Related]
14. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast. Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803 [TBL] [Abstract][Full Text] [Related]
15. Descriptions and outcomes of insertion techniques of a breast brachytherapy balloon catheter in 1403 patients enrolled in the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial. Zannis V; Beitsch P; Vicini F; Quiet C; Keleher A; Garcia D; Snider H; Gittleman M; Kuerer H; Whitacre E; Whitworth P; Fine R; Haffty B; Stolier A; Mabie J Am J Surg; 2005 Oct; 190(4):530-8. PubMed ID: 16164915 [TBL] [Abstract][Full Text] [Related]
16. Early experience with balloon brachytherapy for breast cancer. Dowlatshahi K; Snider HC; Gittleman MA; Nguyen C; Vigneri PM; Franklin RL Arch Surg; 2004 Jun; 139(6):603-7; discussion 607-8. PubMed ID: 15197085 [TBL] [Abstract][Full Text] [Related]
17. A single-institution review of accelerated partial breast irradiation in patients considered "cautionary" by the American Society for Radiation Oncology. Stull TS; Catherine Goodwin M; Gracely EJ; Chernick MR; Carella RJ; Frazier TG; Barrio AV Ann Surg Oncol; 2012 Feb; 19(2):553-9. PubMed ID: 21769461 [TBL] [Abstract][Full Text] [Related]
18. Should ductal carcinoma-in-situ (DCIS) be removed from the ASTRO consensus panel cautionary group for off-protocol use of accelerated partial breast irradiation (APBI)? A pooled analysis of outcomes for 300 patients with DCIS treated with APBI. Vicini F; Shah C; Ben Wilkinson J; Keisch M; Beitsch P; Lyden M Ann Surg Oncol; 2013 Apr; 20(4):1275-81. PubMed ID: 23054123 [TBL] [Abstract][Full Text] [Related]
19. Radiation treatment for ductal carcinoma in situ (DCIS): is a boost to the tumor bed necessary? Yerushalmi R; Sulkes A; Mishaeli M; Neumann A; Dinerman M; Sulkes J; Rizel S; Yarom N; Gutman H; Fenig E Neoplasma; 2006; 53(6):507-10. PubMed ID: 17167720 [TBL] [Abstract][Full Text] [Related]
20. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy. Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]